Afrin NoDrip Allergy Sinus Night
- Product NDC
- 11523-0034
- 11-digit product format
- 115230034
- Labeler code
- 11523
- Product ID
- 11523-0034_4526c193-dd2a-1774-e063-6394a90aabbf
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- oxymetazoline hydrochloride
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- Bayer HealthCare LLC.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-11-09
- Substance
- OXYMETAZOLINE HYDROCHLORIDE
- Active strength
- .5 mg/mL
- Pharmacologic classes
- Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Afrin NoDrip Allergy Sinus Night
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| OXYMETAZOLINE HYDROCHLORIDE | .5 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | K89MJ0S5VY |
| Rxcui | 1000990, 1000992 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11523-0034-1 | Afrin NoDrip Allergy Sinus Night | 15 mL in 1 BOTTLE | SPRAY | 15 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11523-0034 | AFRIN NODRIP ALLERGY SINUS NIGHT (OXYMETAZOLINE HYDROCHLORIDE) SPRAY [BAYER HEALTHCARE LLC.] | 6 | Current NDC, Legacy NDC, 1 package rows | 20241208_b023a571-7e54-7c63-e053-2a95a90a0f78.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11523-0034-1 | 11523003401 | 15 mL in 1 BOTTLE (11523-0034-1) | 15 ml | 2020-11-09 | 0000-00-00 | No | No | Current |